SM/RNP Antibody is an extractable nuclear antigen (ENA) associated with Mixed connective tissue disease (MCTD).
Extractable nuclear antigens (ENA) are autoantibodies in the blood that react with proteins in the cell nucleus. These proteins are known as “extractable” because they can be removed from cell nuclei using saline and represent six main proteins (Ro, La, Sm, RNP, Scl-70 and Jo1).
Autoantibodies are produced when a person’s immune system mistakenly targets and attacks the body’s own tissues. This attack can cause inflammation, tissue damage, and other signs and symptoms that are associated with an autoimmune disorder.
Certain autoimmune disorders are characteristically associated with the presence of one or more anti-ENA antibodies, such as mixed connective tissue disease (MCTD), lupus (SLE), Sjögren syndrome, scleroderma, and polymyositis/dermatomyositis. Autoantibody association can aid in the diagnosis of an autoimmune disorder and help distinguish between other autoimmune disorders.
SM/RNP antibodies are a hallmark of MCTD and are found in the majority of patients with the disease. Their presence can help to distinguish MCTD from other autoimmune diseases with similar clinical features, such as SLE, polymyositis, and SSc. All major clinical criteria for MCTD require the presence of anti-Sm/RNP antibodies. In addition, anti-Sm/RNP antibody levels have been reported to correlate with disease activity.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.